Summary
Cellular Dynamics International Inc (CDI), a subsidiary of Fujifilm Holdings Corp is a biotechnology company that develops and manufactures fully functioning human cells in industrial quantities to precise specifications. The company offers products such as icell cardiomyocytes, icell endothelial cells, icell hepatocytes, icell neurons, icell prototypes and mycell products. CDI also offers Mycell products for the treatment of cardiac diseases, hepatic, musculoskeletal, neural and infectious diseases among others. The company’s products are used for drug discovery and screening, testing the safety and efficacy of their small molecule and biologic drug candidates, stem cell banking, and cell therapy development. CDI is headquartered in Madison, Wisconsin, the US.
Cellular Dynamics International Inc (ICEL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Cellular Dynamics International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Cellular Dynamics International Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Cellular Dynamics International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Cellular Dynamics International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Cellular Dynamics International Inc, Medical Devices Deals, 2011 to YTD 2017 10
Cellular Dynamics International Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Cellular Dynamics International Inc, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
Opsis Therapeutics Raises Funds through Seed Financing 13
Cellular Dynamics International Raises US$12 Million In Venture Financing 13
Cellular Dynamics International Raises US$20 Million In Venture Financing 14
Cellular Dynamics International Raises US$21 Million In Venture Financing 14
Cellular Dynamics International Secures US$30 Million In Series B Preferred Stock Financing 15
Partnerships 16
Cellular Dynamics Enters into Distribution Agreement with Stemcell Technologies 16
Cellular Dynamics International Enters into R&D Agreement with National Eye Institute 17
Cellular Dynamics Enters into Distribution Agreement with Seoulin Bioscience 18
Cord Blood Registry Enters into Research Agreement with Cellular Dynamics 18
Cellular Dynamics International Enters Into Agreement With AstraZeneca On Use Of iPSC-Derived Human Cells In Drug Discovery 19
CeeTox Enters Into Agreement With Cellular Dynamics International To Offer iPSC Cardiac Toxicity Screening 20
Life Technologies Amends Co-Marketing Agreement With Cellular Dynamics International 21
Cellular Dynamics Expands Co-Marketing Agreement With iPS Academia 22
Cellular Dynamics Enters Into Co-Marketing Agreement With iPS Academia 22
Licensing Agreements 23
Cellular Dynamics International Enters into Licensing Agreement with IURTC 23
Roche Enters into Licensing Agreement with Cellular Dynamics 24
Takara Bio Enters Into Licensing Agreement With Cellular Dynamics International For RetroNectin 25
Cellular Dynamics Enters Into Licensing Agreement With Life Technologies And Sigma-Aldrich 26
Cellular Dynamics International Enters Into Licensing Agreement With Life Technologies For TAL Effector Technology 27
GE Healthcare Life Sciences Enters Into Licensing Agreement With Cellular Dynamics For Cellular Assays And Models 27
Cellular Dynamics International Enters into Licensing Agreement with Wisconsin Alumni Research Foundation 28
Cellular Dynamics Enters Into Licensing Agreement With ViaCyte 29
Cellular Dynamics International Enters Into Licensing Agreement With Transposagen BioPharma 30
Transposagen BioPharma Enters Into Licensing Agreement With Cellular Dynamics International 31
Equity Offering 32
Cellular Dynamics International Completes IPO Of Shares For US$46.2 Million 32
Acquisition 34
Fujifilm Acquires Cellular Dynamics for USD238 Million in Tender Offer 34
Cellular Dynamics International Inc - Key Competitors 36
Key Employees 37
Locations And Subsidiaries 38
Head Office 38
Recent Developments 39
Strategy And Business Planning 39
Sep 28, 2016: Cellular Dynamics International Launches Opsis Therapeutics to Develop Cell Therapies for Treatment of Retinal Diseases 39
Product News 40
Sep 22, 2016: Cellular dynamics announces launch of Icell Hepatoblasts to enable research into therapies that stimulate liver regeneration 40
Other Significant Developments 41
Sep 01, 2016: Cellular Dynamics to Realign Business Units to Better Serve Therapeutic and Life Science Customers 41
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42
List of Tables
Cellular Dynamics International Inc, Pharmaceuticals & Healthcare, Key Facts, 2014 1
Cellular Dynamics International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Cellular Dynamics International Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Cellular Dynamics International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Cellular Dynamics International Inc, Deals By Therapy Area, 2011 to YTD 2017 9
Cellular Dynamics International Inc, Medical Devices Deals, 2011 to YTD 2017 10
Cellular Dynamics International Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Opsis Therapeutics Raises Funds through Seed Financing 13
Cellular Dynamics International Raises US$12 Million In Venture Financing 13
Cellular Dynamics International Raises US$20 Million In Venture Financing 14
Cellular Dynamics International Raises US$21 Million In Venture Financing 14
Cellular Dynamics International Secures US$30 Million In Series B Preferred Stock Financing 15
Cellular Dynamics Enters into Distribution Agreement with Stemcell Technologies 16
Cellular Dynamics International Enters into R&D Agreement with National Eye Institute 17
Cellular Dynamics Enters into Distribution Agreement with Seoulin Bioscience 18
Cord Blood Registry Enters into Research Agreement with Cellular Dynamics 18
Cellular Dynamics International Enters Into Agreement With AstraZeneca On Use Of iPSC-Derived Human Cells In Drug Discovery 19
CeeTox Enters Into Agreement With Cellular Dynamics International To Offer iPSC Cardiac Toxicity Screening 20
Life Technologies Amends Co-Marketing Agreement With Cellular Dynamics International 21
Cellular Dynamics Expands Co-Marketing Agreement With iPS Academia 22
Cellular Dynamics Enters Into Co-Marketing Agreement With iPS Academia 22
Cellular Dynamics International Enters into Licensing Agreement with IURTC 23
Roche Enters into Licensing Agreement with Cellular Dynamics 24
Takara Bio Enters Into Licensing Agreement With Cellular Dynamics International For RetroNectin 25
Cellular Dynamics Enters Into Licensing Agreement With Life Technologies And Sigma-Aldrich 26
Cellular Dynamics International Enters Into Licensing Agreement With Life Technologies For TAL Effector Technology 27
GE Healthcare Life Sciences Enters Into Licensing Agreement With Cellular Dynamics For Cellular Assays And Models 27
Cellular Dynamics International Enters into Licensing Agreement with Wisconsin Alumni Research Foundation 28
Cellular Dynamics Enters Into Licensing Agreement With ViaCyte 29
Cellular Dynamics International Enters Into Licensing Agreement With Transposagen BioPharma 30
Transposagen BioPharma Enters Into Licensing Agreement With Cellular Dynamics International 31
Cellular Dynamics International Completes IPO Of Shares For US$46.2 Million 32
Fujifilm Acquires Cellular Dynamics for USD238 Million in Tender Offer 34
Cellular Dynamics International Inc, Key Competitors 36
Cellular Dynamics International Inc, Key Employees 37List of Figures
Cellular Dynamics International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Cellular Dynamics International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Cellular Dynamics International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Cellular Dynamics International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Cellular Dynamics International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Cellular Dynamics International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7
Cellular Dynamics International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Cellular Dynamics International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Cellular Dynamics International Inc, Medical Devices Deals, 2011 to YTD 2017 10
